RS50601B - Derivati 1-fenil alkan karbonskih kiselina za lečenje neurodegenerativnih oboljenja - Google Patents

Derivati 1-fenil alkan karbonskih kiselina za lečenje neurodegenerativnih oboljenja

Info

Publication number
RS50601B
RS50601B RSP-2008/0392A RSP20080392A RS50601B RS 50601 B RS50601 B RS 50601B RS P20080392 A RSP20080392 A RS P20080392A RS 50601 B RS50601 B RS 50601B
Authority
RS
Serbia
Prior art keywords
branched
linear
alkyl
optionally substituted
groups
Prior art date
Application number
RSP-2008/0392A
Other languages
English (en)
Inventor
Luca Raveglia
Ilaria Peretto
Stefano Radaelli
Bruno Pietro Imbimbo
Andrea Rizzi
Gino Villetti
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of RS50601B publication Critical patent/RS50601B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RSP-2008/0392A 2004-08-03 2005-07-26 Derivati 1-fenil alkan karbonskih kiselina za lečenje neurodegenerativnih oboljenja RS50601B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04425604 2004-08-03
PCT/IB2005/002189 WO2006016219A2 (en) 2004-08-03 2005-07-26 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
RS50601B true RS50601B (sr) 2010-05-07

Family

ID=35462580

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0392A RS50601B (sr) 2004-08-03 2005-07-26 Derivati 1-fenil alkan karbonskih kiselina za lečenje neurodegenerativnih oboljenja

Country Status (22)

Country Link
US (1) US7531692B2 (sr)
EP (1) EP1778623B1 (sr)
JP (1) JP4866851B2 (sr)
KR (1) KR101156393B1 (sr)
CN (1) CN1984878B (sr)
AT (1) ATE399758T1 (sr)
AU (1) AU2005270949B2 (sr)
BR (1) BRPI0513647A (sr)
CA (1) CA2576009C (sr)
CY (1) CY1110401T1 (sr)
DE (1) DE602005007912D1 (sr)
DK (1) DK1778623T3 (sr)
ES (1) ES2309778T3 (sr)
HK (1) HK1104280A1 (sr)
HR (1) HRP20080494T3 (sr)
NO (1) NO339921B1 (sr)
PL (1) PL1778623T3 (sr)
PT (1) PT1778623E (sr)
RS (1) RS50601B (sr)
SI (1) SI1778623T1 (sr)
WO (1) WO2006016219A2 (sr)
ZA (1) ZA200700945B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004016729D1 (de) * 2003-02-21 2008-11-06 Chiesi Farma Spa 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
EP2560942B1 (en) 2010-04-21 2014-11-26 Chiesi Farmaceutici S.p.A. 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
KR20130080795A (ko) 2010-06-04 2013-07-15 키에시 파르마슈티시 엣스. 피. 에이. 프리온 질환의 치료를 위한 1-(2-플루오로비페닐-4-일)-시클로프로판카복실산 유도체
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
EP2834214A1 (en) 2012-04-04 2015-02-11 Chiesi Farmaceutici S.p.A. Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases
WO2015181094A1 (en) 2014-05-26 2015-12-03 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome
WO2019099314A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
WO2019099294A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
US6117901A (en) * 1996-11-22 2000-09-12 Athena Neurosciences, Inc. N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
US6211235B1 (en) * 1996-11-22 2001-04-03 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6191166B1 (en) * 1997-11-21 2001-02-20 Elan Pharmaceuticals, Inc. Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
WO1998034115A1 (en) 1997-02-04 1998-08-06 Trega Biosciences, Inc. 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries
US5994379A (en) 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
DE602004016729D1 (de) 2003-02-21 2008-11-06 Chiesi Farma Spa 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen

Also Published As

Publication number Publication date
DE602005007912D1 (de) 2008-08-14
PL1778623T3 (pl) 2008-12-31
HRP20080494T3 (en) 2008-11-30
AU2005270949A1 (en) 2006-02-16
WO2006016219A2 (en) 2006-02-16
HK1104280A1 (en) 2008-01-11
CN1984878A (zh) 2007-06-20
CY1110401T1 (el) 2015-04-29
JP2008509124A (ja) 2008-03-27
SI1778623T1 (sl) 2008-10-31
CN1984878B (zh) 2011-06-08
DK1778623T3 (da) 2008-10-20
EP1778623A2 (en) 2007-05-02
JP4866851B2 (ja) 2012-02-01
PT1778623E (pt) 2008-09-29
CA2576009C (en) 2013-02-26
NO20070665L (no) 2007-05-02
CA2576009A1 (en) 2006-02-16
AU2005270949B2 (en) 2011-02-03
EP1778623B1 (en) 2008-07-02
US20080096968A1 (en) 2008-04-24
NO339921B1 (no) 2017-02-13
US7531692B2 (en) 2009-05-12
ES2309778T3 (es) 2008-12-16
ZA200700945B (en) 2008-09-25
KR101156393B1 (ko) 2012-06-13
BRPI0513647A (pt) 2008-05-13
ATE399758T1 (de) 2008-07-15
KR20070038982A (ko) 2007-04-11
WO2006016219A3 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
RS50601B (sr) Derivati 1-fenil alkan karbonskih kiselina za lečenje neurodegenerativnih oboljenja
Davies et al. Control of competing N− H insertion and Wolff rearrangement in dirhodium (II)-catalyzed reactions of 3-indolyl diazoketoesters. Synthesis of a potential precursor to the marine 5-(3-indolyl) oxazole Martefragin A
DE602005016775D1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
PE20210397A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cancer
RS52520B (sr) Inhibitori akt i p70 s6 kinaze
AR087196A1 (es) Metodos plaguicidas que utilizan compuestos de 3-piridil tiazol sustituido y derivados para combatir las plagas de animales ii
ES2313079T3 (es) Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h.
AR043837A1 (es) Pirazoles sustituidos
RS52261B (sr) Amidofenoksi indazoli kao korisni inhibitori c-met-a
PE20091952A1 (es) Compuestos de tiazole y oxazole de sulfonamida de benzeno
HRP20080070T3 (en) Pyrrazolo-pyrimidine derivatives
ATE497963T1 (de) Pyrrolobenzodiazepine zur behandlung proliferativer erkrankungen
RS51163B (sr) Dihidrotienopirimidin za lečenje zapaljenskih bolesti
CO6260017A2 (es) Compuestos de oxazol, oxadiazol y tiadiazol utiles para el control de nematodos
CO6210770A2 (es) Compuestos 2-aril-5-heterociclil-ciclohexan-1, 3 diona y su uso como herbicidas
AR082891A1 (es) Di-azetidinil diamidas como inhibidores de monoacilglicerol lipasas
CO6241076A2 (es) Compuestos de benzamida y aplicaciones de los mismos
ME01106B (me) Derivati karboksamida kao antagonisti muskarinskih receptora
PE20070518A1 (es) Compuestos de tiofeno bencimidazol como agentes inhibidores de plk
PE20050435A1 (es) Derivados de fenil-piperazina como moduladores de receptores muscarinicos
ATE484502T1 (de) Neue verbindungen
DK1633340T3 (da) Forbindelser til behandling af stofskifteforstyrrelser
CO6260069A2 (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa
ES2530815T3 (es) Tiazolil y oxazolil-isoquinolinonas y métodos para usar las mismas
CR10951A (es) Metodo para inducir tolerancia a virus en plantas